Portal de Periódicos da CAPES

Association of rheumatoid arthritis with a dominant DR1/Dw4/Dw14 sequence motif, but not with t cell receptor β chain gene alleles or haplotypes

1991; Wiley; Volume: 34; Issue: 11 Linguagem: Inglês

10.1002/art.1780341112

1529-0131

Johan Wallin, Jan Hillert, Olle Olerup, Björn Carlsson, Håkan Ström, Johan Wallin, Jan Hillert, Olle Olerup, Björn Carlsson, Håkan Ström,

Immune Cell Function and Interaction

Arthritis & RheumatismVolume 34, Issue 11 p. 1416-1424 ArticleFree to Read Association of rheumatoid arthritis with a dominant DR1/Dw4/Dw14 sequence motif, but not with t cell receptor β chain gene alleles or haplotypes Johan Wallin, Johan Wallin Center for Biotechnology, Karolinska Institute, Novum Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, Huddinge Division of Rheumatology, Department of Medicine, Karolinska Institute, Danderyds Hospital, Stockholm, SwedenSearch for more papers by this authorJan Hillert, Jan Hillert Center for Biotechnology, Karolinska Institute, Novum Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, Huddinge Division of Rheumatology, Department of Medicine, Karolinska Institute, Danderyds Hospital, Stockholm, SwedenSearch for more papers by this authorOlle Olerup, Olle Olerup Center for Biotechnology, Karolinska Institute, Novum Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, Huddinge Division of Rheumatology, Department of Medicine, Karolinska Institute, Danderyds Hospital, Stockholm, SwedenSearch for more papers by this authorBjörn Carlsson, Björn Carlsson Center for Biotechnology, Karolinska Institute, Novum Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, Huddinge Division of Rheumatology, Department of Medicine, Karolinska Institute, Danderyds Hospital, Stockholm, SwedenSearch for more papers by this authorHakan Ström, Hakan Ström Center for Biotechnology, Karolinska Institute, Novum Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, Huddinge Division of Rheumatology, Department of Medicine, Karolinska Institute, Danderyds Hospital, Stockholm, SwedenSearch for more papers by this authorJohan Wallin MD, Phd, Johan Wallin MD, Phd Center for Biotechnology, Karolinska Institute, Novum, the Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, HuddingeSearch for more papers by this authorJan Hillert MD, Jan Hillert MD Center for Biotechnology, Karolinska Institute, Novum, the Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, HuddingeSearch for more papers by this authorOlle Olerup MD, Olle Olerup MD Center for Biotechnology, Karolinska Institute, Novum, the Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, HuddingeSearch for more papers by this authorBjörn Carlsson MD, PHD, Björn Carlsson MD, PHD Center for Biotechnology, Karolinska Institute, Novum, the Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, HuddingeSearch for more papers by this authorHåkan Ström MD, PHD, Corresponding Author Håkan Ström MD, PHD Department of Clinical Immunology, and Division of Rheumatology, Department of MedicineDepartment of Clinical Immunology, Huddinge Hospital, S-141 86 Huddinge, SwedenSearch for more papers by this author Johan Wallin, Johan Wallin Center for Biotechnology, Karolinska Institute, Novum Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, Huddinge Division of Rheumatology, Department of Medicine, Karolinska Institute, Danderyds Hospital, Stockholm, SwedenSearch for more papers by this authorJan Hillert, Jan Hillert Center for Biotechnology, Karolinska Institute, Novum Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, Huddinge Division of Rheumatology, Department of Medicine, Karolinska Institute, Danderyds Hospital, Stockholm, SwedenSearch for more papers by this authorOlle Olerup, Olle Olerup Center for Biotechnology, Karolinska Institute, Novum Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, Huddinge Division of Rheumatology, Department of Medicine, Karolinska Institute, Danderyds Hospital, Stockholm, SwedenSearch for more papers by this authorBjörn Carlsson, Björn Carlsson Center for Biotechnology, Karolinska Institute, Novum Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, Huddinge Division of Rheumatology, Department of Medicine, Karolinska Institute, Danderyds Hospital, Stockholm, SwedenSearch for more papers by this authorHakan Ström, Hakan Ström Center for Biotechnology, Karolinska Institute, Novum Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, Huddinge Division of Rheumatology, Department of Medicine, Karolinska Institute, Danderyds Hospital, Stockholm, SwedenSearch for more papers by this authorJohan Wallin MD, Phd, Johan Wallin MD, Phd Center for Biotechnology, Karolinska Institute, Novum, the Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, HuddingeSearch for more papers by this authorJan Hillert MD, Jan Hillert MD Center for Biotechnology, Karolinska Institute, Novum, the Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, HuddingeSearch for more papers by this authorOlle Olerup MD, Olle Olerup MD Center for Biotechnology, Karolinska Institute, Novum, the Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, HuddingeSearch for more papers by this authorBjörn Carlsson MD, PHD, Björn Carlsson MD, PHD Center for Biotechnology, Karolinska Institute, Novum, the Department of Clinical Immunology, and the Department of Neurology, Karolinska Institute, Huddinge Hospital, HuddingeSearch for more papers by this authorHåkan Ström MD, PHD, Corresponding Author Håkan Ström MD, PHD Department of Clinical Immunology, and Division of Rheumatology, Department of MedicineDepartment of Clinical Immunology, Huddinge Hospital, S-141 86 Huddinge, SwedenSearch for more papers by this author First published: November 1991 https://doi.org/10.1002/art.1780341112Citations: 26AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume34, Issue11November 1991Pages 1416-1424 RelatedInformation